BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Stocks Nasdaq'. (Return)

MarketWatch MarketPulseOct 01, 2020
Stocks open higher, with all eyes on Washington stimulus
U.S. stocks opened higher Thursday as investors held out hope for a last-ditch deal on another round of coronavirus fiscal aid. The Dow Jones Industrial Average gained 177 points, 0.6%, to open near 27,958, while the S&P 500 was up 26 points or 0.8% to 3,389. The Nasdaq Composite popped 1.1%, 123 points, and traded near 11,291. The White House and House Democrats have both signaled that each wants to make a deal, if at all possible, but both have reiterated that they remain far apart on many of the details. Meanwhile, furloughs begin today for tens of thousands of airline employees. Shares of Bed Bath & Beyond Inc. jumped after the bell after the home-goods retailer reported earnings that beat Wall Street expectations.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



MarketWatch MarketPulseOct 01, 2020
Mission Produce shares soar 18% as trading begins
Mission Produce Inc. shares jumped 18.8% after trading began Thursday at 12:15 pm ET. The avocado company priced at $12 on Wednesday, below the price range between $15 to $17. Mission Produce also downsized its IPO, offering 8 million shares, down from 9,375,000 shares previously. Mission Produce is trading under the ticker "AVO" on the Nasdaq. BofA Securities, JPMorgan and Citigroup were the active bookrunners. Proceeds from the IPO will be used for general corporate purposes and working capital. The California-based company has packing facilities in the U.S., Mexico and Peru and 11 distribution and ripening centers around the world.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.



MarketWatch MarketPulseOct 01, 2020
Pulmonx shares soar 118% in trading debut
Shares of Pulmonx, a maker of treatments for lung diseases including emphysema, rose 118% in their trading debut Thursday, after the company's initial public offering priced above range. The deal priced at $19 a share, above its proposed price range of $17 to $18. The company upsized the deal on Wednesday and raised the proposed price range. Pulmonx sold 10 million shares to raise $190 million. Shares are trading on Nasdaq under the ticker "LUNG." BofA, and Morgan Stanley were lead underwriters on the deal, with Stifel, Wells Fargo and Canaccord acting as co-managers. Proceeds of the deal will be used to hire sales and marketing people, fund R&D, to pay a success fee to Oxford of $1.9 million and for working capital. "We are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD)," the company says in its prospectus.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.


TRENDING TAGS
Covid-19vaccine pandemic Trump will FDA
Pandemicduring Coronavirus Covid-19 demand safe
Coronaviruslatest vaccine Pandemic wont update
StimulusDow hopes points stocks higher
Stocksstimulus higher hopes since March
GooglePixel Chromecast TV Alternative Nest
Trumpdebate Biden Trump-Biden campaign food
Duringpandemic debate times Covid Crisis
FilerInc LLC 8-K Corp Trust
DealStimulus markets will GMA American

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC